Atlantic Health Strategies logo
LinkedIn icon
Contact Us

Atlantic Health Strategies

X-twitter Linkedin
Atlantic Health Strategies Logo

The Joint Commission’s RUAIH Guidance: What Behavioral Health Operators Actually Have to Do

Table of Contents

Ready to See Results?

From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.

Contact Us

The Short Answer: What RUAIH Requires of You

The Responsible Use of AI in Healthcare (RUAIH) guidance, jointly published by The Joint Commission and the Coalition for Health AI on September 17, 2025, is not a regulation. It is a governance framework built around seven elements: AI policies and governance, patient privacy and transparency, data security, ongoing quality monitoring, voluntary blinded safety-event reporting, risk and bias assessment, and education and training. If you are a Joint Commission-accredited behavioral health organization, treat it as the early blueprint for a voluntary AI certification program that is coming next.

The guidance landed the same week Joint Commission held its inaugural UNIFY conference in Washington, D.C. Dr. Jonathan Perlin, president and CEO of Joint Commission, framed the urgency directly, saying AI is changing healthcare at a scale he had never seen as a leader. CHAI CEO Dr. Brian Anderson said “The need is immediate, and we are eager to respond.”

For AHS clients operating residential, PHP, and IOP programs in Florida, Texas, and Arizona, here is the practical translation: build the governance file now, before the playbook drops and before a surveyor asks how you validated the scribe, the utilization-management triage tool, or the outreach chatbot your marketing team plugged in last quarter.

Why This Guidance Arrived Now (The Adoption Numbers Tell the Story)

The Joint Commission did not publish RUAIH in a vacuum. AI is already inside the operational backbone of most U.S. Hospitals, and behavioral health is catching up fast.

The governance gap is the part that should worry operators. In 2024, only 57% of hospitals reported evaluating all or most of their models for bias, up from 44% in 2023. That means roughly four in ten hospitals were running predictive models without a bias-evaluation discipline. The AHA also reported that rural hospitals lag urban ones at 56% adoption versus 81%, and critical access hospitals trail at 50%. Behavioral health, where margins are thinner and IT budgets smaller than acute care, sits inside that same disparity curve.

The Seven Elements, Translated for a Behavioral Health Operator

The Joint Commission and CHAI organized RUAIH around seven elements. Fenwick’s regulatory team summarized them as AI policy and governance structures, patient privacy and transparency, data security and data use protections, ongoing quality monitoring, voluntary blinded reporting of AI safety events, risk and bias assessment, and education and training. Here is how an MSO actually operationalizes each one inside a 60-bed residential program in West Palm Beach or a multi-site IOP network in Houston.

  1. Governance: Your governance committee needs a named owner, a defined charter, and seats for compliance, clinical leadership, IT, HR, and a board representative. The guidance specifically calls for regular reporting on AI usage to the board or other fiduciary body.
  2. Privacy and transparency: Patients deserve to know when an AI tool influenced a clinical decision. Disclose it. Document it.
  3. Data security: RUAIH layers AI-specific protections on top of HIPAA, including defining permitted uses of exported data, minimum-necessary data export, explicit prohibitions on re-identification, and strengthened third-party obligations and audit rights. Pull every vendor BAA and check it against that list.
  4. Quality monitoring: Models drift. Validate on a schedule, not when something breaks.
  5. Blinded reporting: The Joint Commission encourages organizations to use existing channels such as Patient Safety Organizations or the sentinel-event process, and to contribute de-identified reports to CHAI’s Health AI Registry.
  6. Bias assessment: Evaluate vendor testing data against your actual census. A model trained primarily on adult co-occurring populations in the Midwest may misfire on adolescent SUD populations in South Florida.
  7. Education: Clinicians, intake staff, and billing teams all need training calibrated to the AI tools they actually touch.

Why Behavioral Health Operators Should Move Before the Playbook Drops

RUAIH is non-binding today. That will not stay true. The Joint Commission has announced that governance playbooks will follow in 2025-2026 and that a voluntary AI certification program will be available to its more than 22,000 accredited and certified healthcare organizations. Certification programs become de facto expectations fast, especially for payers running SIU audits and for private-equity buyers running diligence on a platform deal.

The downstream pressure is already visible. Hooper Lundy’s regulatory team notes that adoption of RUAIH recommendations may reduce exposure to claims of negligent or improper incorporation of AI into care delivery, and that insurers may eventually require or offer better terms to organizations that adopt strong governance frameworks. Translation: your malpractice carrier, your D&O carrier, and your cyber carrier will all start asking AI governance questions on renewal.

The FDA piece is also moving. The Bipartisan Policy Center reported that as of July 2025 the FDA’s public database lists more than 1,250 AI-enabled medical devices, up from 950 in August 2024. The FDA regulates the device. RUAIH governs how you deploy and monitor it once it is inside your walls. Both layers apply, and surveyors will expect you to know the difference.

What AHS Tells Clients to Do This Quarter

If you are a behavioral health operator running facilities in Florida, Texas, or Tennessee, here is the 90-day list our compliance team gives every client.

  • Inventory every AI tool in use. Ambient scribes, intake chatbots, utilization-management triage, claim-scrubbing, marketing automation, predictive census tools. If an algorithm influences a decision, it goes on the list.
  • Stand up a governance committee with a charter. Compliance, clinical leadership, IT, HR, and one board liaison. Meet quarterly. Document everything.
  • Pull every vendor BAA and confirm it addresses re-identification, model training rights, and audit rights. If it does not, renegotiate.
  • Add an AI module to your annual staff training. Cover what each tool does, what it does not do, and how to escalate a suspected error or bias.
  • Build an internal blinded reporting channel so staff can flag AI near-misses without fear, and connect it to your existing incident-reporting workflow.

Do this now and a Joint Commission surveyor asking AI questions in your next survey window becomes a non-event. Do it after the playbook drops and you are reacting under deadline pressure. We have watched both versions play out. The first one costs less.

Frequently asked questions

Is the RUAIH guidance a regulation that Joint Commission surveyors will cite against my facility?

Not today. RUAIH is non-binding guidance, jointly published by The Joint Commission and the Coalition for Health AI on September 17, 2025. Joint Commission has been clear that adoption does not currently affect accreditation decisions. However, governance playbooks are launching in 2025-2026 and a voluntary AI certification program will follow, available to the more than 22,000 organizations Joint Commission accredits. Treat RUAIH as the blueprint for what surveyors will likely ask about within the next two survey cycles.

Does RUAIH apply to behavioral health organizations or only to acute care hospitals?

It applies broadly. RUAIH defines health AI tools to include clinical, administrative, and operational solutions across direct patient care, care support, and administrative services like revenue cycle, prior authorization, and care coordination. Behavioral health residential, PHP (ASAM Level 2.5 outpatient), and IOP programs use AI in scheduling, utilization management, claim scrubbing, and ambient documentation today. All of it falls inside the framework’s scope.

How does RUAIH interact with FDA oversight of AI-enabled medical devices?

The two regulators handle different parts of the lifecycle. The FDA authorizes the device or software before market entry; the Bipartisan Policy Center reported more than 1,250 AI-enabled medical devices on the FDA list as of July 2025. RUAIH governs how your organization implements, validates, monitors, and retires that tool once it is inside your facility. Operators need a governance file that addresses both layers, including vendor Predetermined Change Control Plans the FDA finalized guidance on in December 2024.

What is the single most important thing a behavioral health operator can do this quarter on AI governance?

Build a complete AI tool inventory and a named governance committee charter. Most operators we work with in Florida and Texas cannot list every AI tool currently touching their patient data, billing flow, or clinical documentation. The inventory drives everything else: vendor BAA review, bias assessment, staff training, and incident reporting. Without it, the other six RUAIH elements have nothing to attach to.

References

Request a Free Consultation

Scroll to Top